DATE
04/11/2022 - 06/11/2022
TOTAL VIEWS
14705
Google Calendar
ICal
Outlook
Homepage
Videos on Demand
Scientific Program
Contact
Sponsors
e-Certificate
Videos On Demand
04/11/2022
11.30-13.30 The Most Impactful Antithrombotic Trials in 2021-2022
13.30-14.30 Meet the Experts: From ACS to chronic coronary artery disease. The transition period
15.30-16.30 Interactive Workshop. Real-World Data on Thrombosis Incidence and Treatment in Countries Affiliated to EMLTD
16.30-17.00 Antithrombotic Therapy in cardiac Operations
17.30-19.00 Plenary Session. Stroke therapeutics: an update
19.00-20.00 Plenary Session. Cardiovascular complications in cancer patients
20.20-20.45 Official Opening of ALPIC 2022
20.45-21.10 Opening Lecture
05/11/2022
08.30-10.00 Atrial fibrillation and the Prothrombotic state: New insights for 2021-2022
10.30-11.30 How to Treat Session. Practical Guidance in Antithrombotic Therapy
11.30-12.00 Satellite Lecture
12.00-13.00 Meet the Experts session: Unaddressed issues in Thrombosis and Haemostasis
13.00-14.30 Clinical Seminar. Management of acute ischemic stroke
15.30-17.00 Meet the Experts. Management of thrombosis at unusual sites. Which antithrombotic and for how long?
17.00-17.30 Keynote Lecture
18.00-20.00 Plenary Session. Cardiometabolic Risk Factors and Thrombosis. From Pathophysiology to Therapy
20.00-21.00 Keynote Lectures. Recent guidelines on antithrombotic management
06/11/2022
09.00-11.00 Pathogenesis of ischemic stroke: Heart and Vessels
11.30-13.15 Challenging the risk and management of venous thromboembolism in Women
04/11/2022
11.30-13.30 The Most Impactful Antithrombotic Trials in 2021-2022
HEP-COVID | Matilda Florentin
193 Views
MICHELLE, Μελέτη INVICTUS | Theodora Babali
185 Views
REMAP-CAP, ACTIV-4a, and ATTACC | Georgia Kaiafa
197 Views
MASTER DAPT | Dimitrios Nikas
189 Views
ADAPT-TAVR | Georgios Almpanis
183 Views
STOPDAPT-2 ACS | Dimitrios Alexopoulos
175 Views
IMPROVE VTE (Hospitalized medically ill patients) | Ioannis Koulas
181 Views
PACIFIC Program (AF, AMI, STROKE) | John Goudevenos
197 Views
13.30-14.30 Meet the Experts: From ACS to chronic coronary artery disease. The transition period
P2Y12 Μonotherapy following PCI. An alternative approach | Dimitrios Alexopoulos
236 Views
Dual anti platelet therapy duration? Very short or very long? | John Kanakakis
189 Views
Very low dose of rivaroxaban. It is time for a new era in antithrombotic treatment? | Christos Katsouras
178 Views
The bleeding risk. The true game changer? | Georgios Almpanis
188 Views
15.30-16.30 Interactive Workshop. Real-World Data on Thrombosis Incidence and Treatment in Countries Affiliated to EMLTD
Interactive Workshop. Real-World Data on Thrombosis Incidence and Treatment in Countries Affiliated to EMLTD
202 Views
16.30-17.00 Antithrombotic Therapy in cardiac Operations
Antithrombotic therapy of patients undergoing noncardiac operations according to 2022 ESC guidelines | Michail Botis
230 Views
Antithrombotic Therapy in Patients Undergoing Transcatheter interventions for Structural Heart Disease | Gregoris Pattakos
171 Views
17.30-19.00 Plenary Session. Stroke therapeutics: an update
Tenecteplase vs alteplase for iv thrombolysis in Acute Ischemic Stroke Georgios Tsivgoulis
194 Views
Combination of antiplatelets and anticoagulants for secondary stroke prevention | Lina Palaiodimou
172 Views
Inhibition of factor XI: a new therapeutic horizon for secondary stroke prevention | John Ellul
183 Views
Inflammation: a new therapeutic target for atherothrombotic stroke prevention | Odysseas Kargiotis
172 Views
19.00-20.00 Plenary Session. Cardiovascular complications in cancer patients
Evolving data on cardiovascular complications in cancer | Nikos Tsoukalas
178 Views
Venous Thromboembolism and Risk Stratification in Hematological Malignancies Georgia Kaiafa
169 Views
Cardiotoxicity of Cardiovascular drugs. Focus on antithrombotics | Alexandros Tselepis
170 Views
Optimizing antithrombotic therapy for atrial fibrillation in cancer Georgios Andrikopoulos
182 Views
20.20-20.45 Official Opening of ALPIC 2022
Official Opening of ALPIC 2022
190 Views
20.45-21.10 Opening Lecture
Deep Learning and Artificial Intelligence | Panos Vardas
197 Views
05/11/2022
08.30-10.00 Atrial fibrillation and the Prothrombotic state: New insights for 2021-2022
Prothrombotic conditions and Stroke | Georgia Kaiafa
167 Views
Stroke risk assessment in AF: Simplicity and practicality matter | Dimitrios Richter
170 Views
Bleeding risk assessment: Its appropriate use and inappropriate mis-use | Vitorio Pengo
173 Views
Biomarkers for risk stratification in AF Stylianos Tzeis
181 Views
10.30-11.30 How to Treat Session. Practical Guidance in Antithrombotic Therapy
Α 35 year-old woman diagnosed with unprovoked DVT. How far should we extend the antithrombotic treatment? | Kalliroi Kalantzi
178 Views
A 72 year old patient with colonic cancer and pulmonary embolism | Stavroula Tsiara
178 Views
A 70 Years Old Patient with Atrial Fibrillation on DOAC and Melena | Athanasios Pipilis
180 Views
Stroke management in COVID-19 patients in the Internal Medicine Unit of a Reference Hospital |Christos Savopoulos
175 Views
11.30-12.00 Satellite Lecture
PCI/ACS and Atrial Fibrillation - Optimal Antithrombotic treatment | John Kanakakis
197 Views
12.00-13.00 Meet the Experts session: Unaddressed issues in Thrombosis and Haemostasis
Diagnostic and therapeutic approach to a bleeding patient with normal routine coagulation tests | Despina Adamidou
230 Views
13.00-14.30 Clinical Seminar. Management of acute ischemic stroke
Dissolve thrombus. What to expect? | Dimitris Sagris
169 Views
Retrieving emboli. Where do we stand? | Panagiotis Papanagiotou
168 Views
15.30-17.00 Meet the Experts. Management of thrombosis at unusual sites. Which antithrombotic and for how long?
Splanchnic thrombosis | Georgios Glantzounis
173 Views
Cerebral sinus thrombosis | Konstantinos Vemmos
185 Views
Upper extremity thrombosis | Athanasios Gianoukas
185 Views
17.00-17.30 Keynote Lecture
Remote monitoring of cardiometabolic disease patients | Apostolos Pappas
180 Views
18.00-20.00 Plenary Session. Cardiometabolic Risk Factors and Thrombosis. From Pathophysiology to Therapy
Major dietary patterns and atherothrombotic disease; from epidemiology to clinical practice | Demosthenes Panagiotakos
171 Views
Postprandial dysmetabolism - A daily stressor of platelets? | Tzortzis Nomikos
172 Views
"GLP-1 receptor agonists and stroke primary prevention" | Theodosios Philippatos
172 Views
Metabolic Syndrome – Diabetes Mellitus and the risk of LEAD | Nikolaos Tentolouris
171 Views
Lp(a) and Thromboembolic Risk. Present and future | Alexandros Tselepis
152 Views
Reduction of ischemic events with the use of PCSK9 inhibitors. Results from recent clinical trials | Evangelos Liberopoulos
138 Views
20.00-21.00 Keynote Lectures. Recent guidelines on antithrombotic management
2022 ACCP perioperative antithrombotic management guidelines | James Douketis
163 Views
2002 ISTH COVID anticoagulation guidelines | James Douketis - Alex Spyropoulos
160 Views
06/11/2022
09.00-11.00 Pathogenesis of ischemic stroke: Heart and Vessels
Hypertension and ischemic stroke: from pathophysiology to effective management | Nikolaos Kakaletsis
184 Views
Lp (a) and stroke: potential relationship, attributable risk and management | Matilda Florentin
157 Views
PFO: to close or not to close? | Paraskevi Savvari
172 Views
CAS vs. CAE: Pros and cons | Dimitrios Nikas
164 Views
Thrombophilia and stroke: an innocent bystander? | Georgia Kaiafa
161 Views
11.30-13.15 Challenging the risk and management of venous thromboembolism in Women
Hormonal therapy and risk of thrombosis | Ploutarchos Tzoulis
167 Views
Special issues regarding the Prophylaxis and Therapy of VTE in women of all ages | Eleftheria Lefkou
167 Views
Post-thrombotic syndrome in women | Konstantinos Konstantinides
162 Views
Thrombosis and Placenta | Vasileios Papadopoulos
168 Views
Scientific Program
×
.mp4_snapshot_00.01.282.jpg)
